Walleye Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Walleye Capital's NVCR Position: Q3 2026 in Review
Walleye Capital sold out of NovoCure (NVCR) in Q3 2026, closing a stake of 1,535 shares — an estimated $23.3K sold.
Walleye Capital first reported a position in NVCR in Q1 2019 and held it in 17 quarters. The position peaked at $2.8M in Q3 2025. 242 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- Walleye Capital reported no remaining NovoCure position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 1,535 NovoCure shares in Q3 2026, an estimated $23.3K.
- Walleye Capital first reported a position in NovoCure in Q1 2019 and held it in 17 quarters.
- Walleye Capital's NovoCure position peaked at $2.8M in Q3 2025.
- 242 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.